Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Adial Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −1 vs. Q4 2021
- Shares held
- 3.17M
- +1.83M (+137.2%) vs. Q4 2021
- Total value
- $6.38M
- +$2.77M (+76.8%) vs. Q4 2021
- New holders
- 4
- 6 more added
- Sold out
- 5
- 2 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $334.6K |
| Q1 2026 | 15 | $63.8K |
| Q4 2025 | 24 | $778.4K |
| Q3 2025 | 17 | $214.8K |
| Q2 2025 | 17 | $70.8K |
| Q1 2025 | 14 | $152.7K |
| Q4 2024 | 15 | $298.1K |
| Q3 2024 | 12 | $195.9K |
| Q2 2024 | 16 | $328.0K |
| Q1 2024 | 16 | $236.2K |
| Q4 2023 | 17 | $495.3K |
| Q3 2023 | 11 | $164.2K |
| Q2 2023 | 21 | $488.2K |
| Q1 2023 | 23 | $876.9K |
| Q4 2022 | 23 | $359.2K |
| Q3 2022 | 28 | $692.1K |
| Q2 2022 | 26 | $2.27M |
| Q1 2022 | 23 | $6.38M |
| Q4 2021 | 24 | $3.61M |
| Q3 2021 | 21 | $5.50M |
| Q2 2021 | 19 | $3.15M |
| Q1 2021 | 20 | $1.95M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Adial Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,817,454 | $3.65M | 0.10% | +1,817,454 | New |
| Vanguard Group Inc | 590,852 | $1.19M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 225,477 | $454.0K | 0.00% | −1,701−0.7% | Reduced |
| Geode Capital Management, LLC | 135,102 | $271.0K | 0.00% | +5,775+4.5% | Added |
| State Street Corp | 52,354 | $105.0K | 0.00% | +2,200+4.4% | Added |
| Raffa Wealth Management, LLC | 41,845 | $84.1K | 0.03% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 38,500 | $77.0K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 36,461 | $73.0K | 0.00% | 00.0% | Unchanged |
| Empirical Financial Services, LLC d.b.a. Empirical Wealth Management | 35,000 | $70.0K | 0.00% | +35,000 | New |
| Private Advisor Group, LLC | 34,150 | $69.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 31,410 | $63.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 29,299 | $59.0K | 0.00% | 00.0% | Unchanged |
| Brown Advisory Inc | 26,040 | $52.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 19,958 | $40.0K | 0.00% | +19,958 | New |
| Susquehanna International Group, LLP | 18,117 | $36.0K | 0.00% | +5,925+48.6% | Added |
| Group One Trading, L.P. | 13,189 | $27.0K | 0.00% | +6,989+112.7% | Added |
| Advisor Group Holdings, Inc. | 8,321 | $25.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 6,840 | $14.0K | 0.00% | +3,216+88.7% | Added |
| Tower Research Capital LLC (TRC) | 5,289 | $11.0K | 0.00% | +5,289 | New |
| Benjamin F. Edwards & Company, Inc. | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| High Net Worth Advisory Group LLC | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 968 | $2.00K | 0.00% | +103+11.9% | Added |
| Morgan Stanley | 535 | $1.00K | 0.00% | −3−0.6% | Reduced |
| Millennium Management LLC | 0 | $0 | 0.00% | −20,746−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −19,526−100.0% | Sold out |
| Rede Wealth, LLC | 0 | $0 | 0.00% | −15,200−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −11,609−100.0% | Sold out |
| Cornerstone Advisory, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |